VINCOV-19
- Hyderabad
Hyderabad: UoH, CCMB’s COVID-19 antidote completes Phase 2 clinical trials
Hyderabad: The University of Hyderabad (UoH) and the Centre for Cellular and Molecular Biology (CCMB) in collaboration with VINCOV-19, developed the first antidote against COVID-19 and have successfully completed the Phase 2…
- Hyderabad
Hyderabad-based VINS Bioproducts gets DCGI nod to start clinical trials for VINCOV-19
Hyderabad: VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19, the Hyderabad based…
